Japan’s Slow Generic Use Caused By Physician Attitudes, Survey Says
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Generic drugs' penetration into the Japanese pharmaceutical market has been languishing below 20 percent, and as many as 83 percent of consumers said their physicians have not recommended they switch from brand drugs, according to a survey released by research firm Ishare, Oct. 20
You may also be interested in...
MHLW Reports Little Progress In Japan’s Generic Drug Use
Ministry of Health Labor and Welfare Minister Yoichiro Masuzoe and Treasury Minister Shoichi Nakagawa Dec. 18 announced a plan of reducing ¥220 billion in social insurance growth for fiscal year 2009, in which the real reduction will come from ¥23 billion as a result of generic drug use. However, a report released Dec. 15 by MHLW painted a discouraging picture of generic drug use in Japan, even amidst several pushes from the ministry to promote usage during the year.
MHLW Reports Little Progress In Japan’s Generic Drug Use
Ministry of Health Labor and Welfare Minister Yoichiro Masuzoe and Treasury Minister Shoichi Nakagawa Dec. 18 announced a plan of reducing ¥220 billion in social insurance growth for fiscal year 2009, in which the real reduction will come from ¥23 billion as a result of generic drug use. However, a report released Dec. 15 by MHLW painted a discouraging picture of generic drug use in Japan, even amidst several pushes from the ministry to promote usage during the year.
Japan Seeks ¥20 Billion In Spending Cuts With Generic Utilization
TOKYO - Japan Prime Minister Taro Aso's government Dec. 16 unveiled a draft proposal to finance natural social security expenditures growth in fiscal 2009 partly with ¥20 billion in spending cuts for prescription drugs by encouraging the use of generic drugs